Published in Res Commun Chem Pathol Pharmacol on July 01, 1986
Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology (2001) 4.84
Violence in the emergency department: a survey of health care workers. CMAJ (1999) 3.31
Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis. Neurology (2009) 2.70
Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol (2001) 2.60
Hospital volume and stroke outcome: does it matter? Neurology (2007) 2.07
CT assessment of conjugate eye deviation in acute stroke. Neurology (2003) 2.04
Dental HIV transmission? Nature (1993) 2.04
Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry (2005) 1.86
Equipoise among recanalization strategies. Neurology (2010) 1.77
Unexpected posthemorrhagic hydrocephalus in patients treated with rFVIIa. Neurology (2006) 1.75
Refractory neurosarcoidosis responding to infliximab. Neurology (2002) 1.72
Acute ischemic lesions of varying ages predict risk of ischemic events in stroke/TIA patients. Neurology (2007) 1.66
Regional leptomeningeal score on CT angiography predicts clinical and imaging outcomes in patients with acute anterior circulation occlusions. AJNR Am J Neuroradiol (2011) 1.49
Carotid stenting in asymptomatic carotid stenosis: the Calgary experience. Can J Neurol Sci (2010) 1.38
Outcomes after carotid angioplasty and stenting in symptomatic octogenarians. Can J Neurol Sci (2011) 1.38
Predictors of good outcome after intravenous tPA for acute ischemic stroke. Neurology (2001) 1.37
Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke. Neurology (2007) 1.22
The Alberta Stroke Program Early CT Score in clinical practice: what have we learned? Int J Stroke (2009) 1.19
Hyperdense sylvian fissure MCA "dot" sign: A CT marker of acute ischemia. Stroke (2001) 1.17
The rise and fall of NMDA antagonists for ischemic stroke. Curr Mol Med (2004) 1.16
Role of recanalization in acute stroke outcome: rationale for a CT angiogram-based "benefit of recanalization" model. AJNR Am J Neuroradiol (2008) 1.11
Annualized incidence and spectrum of illness from an outbreak investigation of Bell's palsy. Neuroepidemiology (2002) 1.11
Endocrine studies in a patient with a gonadotropin-secreting bronchogenic carcinoma. J Clin Endocrinol Metab (1968) 1.11
The ALIAS (ALbumin In Acute Stroke) Phase III randomized multicentre clinical trial: design and progress report. Biochem Soc Trans (2006) 1.10
Functional and structural defects in HIV type 1 nef genes derived from pediatric long-term survivors. AIDS Res Hum Retroviruses (2000) 1.02
Silent ischemia in minor stroke and TIA patients identified on MR imaging. Neurology (2005) 1.01
The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state. Clin Pharmacokinet (1988) 1.00
Computed tomography and computed tomography angiography findings predict functional impairment in patients with minor stroke and transient ischaemic attack. Int J Stroke (2009) 0.99
Trends in hospital admission for stroke in Calgary. Can J Neurol Sci (2004) 0.98
Prenatal stress, moderate fetal alcohol, and dopamine system function in rhesus monkeys. Neurotoxicol Teratol (2004) 0.96
Strange baryon resonance production in sqrt s NN=200 GeV p+p and Au+Au collisions. Phys Rev Lett (2006) 0.96
Serum procalcitonin as an index of inhalation injury in burns. Horm Metab Res (1992) 0.94
Moderate alcohol during pregnancy: learning and behavior in adolescent rhesus monkeys. Alcohol Clin Exp Res (2001) 0.94
Incidence of Guillain-Barré syndrome in Alberta, Canada: an administrative data study. J Neurol Neurosurg Psychiatry (2007) 0.94
Serum urate in healthy men. Intermittent elevations and seasonal effect. N Engl J Med (1972) 0.94
Transverse-momentum and collision-energy dependence of high-pT hadron suppression in Au+Au collisions at ultrarelativistic energies. Phys Rev Lett (2003) 0.93
Interaction of phenobarbital with propranolol in the dog. 3. Beta blockade. J Pharmacol Exp Ther (1983) 0.92
Sarcoidosis and hyperparathyroidism. Am J Med (1969) 0.92
Evidence from d+Au measurements for final-state suppression of high-p(T) hadrons in Au+Au collisions at RHIC. Phys Rev Lett (2003) 0.92
Timing of moderate alcohol exposure during pregnancy and neonatal outcome in rhesus monkeys (Macaca mulatta). Alcohol Clin Exp Res (2001) 0.92
Negative daily events, positive and negative social ties, and psychological distress among older adults. Gerontologist (1990) 0.92
Calcitonin heterogeneity in lung cancer and medullary thyroid cancer. Acta Endocrinol (Copenh) (1978) 0.91
Increased serum and urinary calcitonin levels in patients with pulmonary disease. Chest (1981) 0.89
Insular cortical ischaemia does not independently predict acute hypertension or hyperglycaemia within 3 h of onset. J Neurol Neurosurg Psychiatry (2006) 0.89
The probability of middle cerebral artery MRA flow signal abnormality with quantified CT ischaemic change: targets for future therapeutic studies. J Neurol Neurosurg Psychiatry (2004) 0.88
Calcitonin as a marker for bronchogenic cancer: a prospective study. Cancer (1979) 0.88
Interactions of phenobarbital with propranolol in the dog. 1. Plasma protein binding. J Pharmacol Exp Ther (1982) 0.88
Dust exposures in the Canadian grain industry. Am Ind Hyg Assoc J (1978) 0.88
Calcitonin in extrathyroidal tissues of man. Acta Endocrinol (Copenh) (1979) 0.86
Methadone plasma protein binding: alterations in cancer and displacement from alpha 1-acid glycoprotein. Clin Pharmacol Ther (1982) 0.86
Complications of diuresis in the alcoholic patient with ascites: a controlled trial. Gastroenterology (1977) 0.86
Differences in stroke outcome based on sex. Neurology (2010) 0.85
Calcitonin levels in thyroid-vein blood of man. Am J Med Sci (1975) 0.85
High cardiovascular event rates in patients with asymptomatic carotid stenosis: the REACH Registry. Eur J Neurol (2009) 0.85
Achieving faster recanalization times by IA thrombolysis in acute ischemic stroke: where should we direct our efforts? Interv Neuroradiol (2011) 0.85
Intra-arterial thrombolysis for retinal artery occlusion: the Calgary experience. Can J Neurol Sci (2005) 0.84
Wallerian-like degeneration after ischemic stroke revealed by diffusion--weighted imaging. Can J Neurol Sci (2007) 0.84
Kinetic models of induction: I. Persistence of the inducing substance. J Pharm Sci (1986) 0.83
Heritable bone disease and stroke due to vertebral artery dissection. Cerebrovasc Dis (2001) 0.83
On marching to two different drummers: perceptual aspects of the difficulties. J Exp Psychol Hum Percept Perform (1985) 0.83
Improved HPLC separation of radiolabelled hormonal peptides. Horm Metab Res (1988) 0.82
Judgment processes for medication acceptance: self-reports and configural information use. Med Decis Making (1994) 0.82
The Tat and C2-V3 envelope genes in the molecular epidemiology of human immunodeficiency virus-1. Virology (1996) 0.82
Elliptic flow in Au+Au collisions at square root(S)NN = 130 GeV. Phys Rev Lett (2001) 0.82
The ASPIRE approach for TIA risk stratification. Can J Neurol Sci (2011) 0.82
A controversy in scaling of subjective states: magnitude estimation versus category rating methods. Res Nurs Health (1994) 0.82
Radioimmunoassay of calcitonin in normal human urine. Anal Chem (1978) 0.82
Outcome in hyperglycemic stroke with ultrasound-augmented thrombolytic therapy. Neurology (2006) 0.82
Acute stroke: evaluation and treatment. Evid Rep Technol Assess (Summ) (2005) 0.82
A health risk benchmark for the neurologic effects of styrene: comparison with NOAEL/LOAEL approach. Risk Anal (2001) 0.82
Femtomole level of analysis of biogenic amines and amino acids using functional group mass spectrometry. Anal Biochem (1974) 0.81
The infrequency of hypercalcemia in sarcoidosis. Am J Med (1971) 0.81
The development of perspective taking: understanding differences in information and weighting. Child Dev (1990) 0.81
Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics. J Pharmacol Exp Ther (1983) 0.81
The kinetics of induction by rifampin of alpha 1-acid glycoprotein and antipyrine clearance in the dog. Drug Metab Dispos (1986) 0.80
The surgical implications of hypercalcitonemia. Surg Gynecol Obstet (1982) 0.80
Measuring DNA synthesis rates with [1-13C]glycine. Anal Chem (1998) 0.80
Predicting final disposition after stroke using the Orpington Prognostic Score. Can J Neurol Sci (2004) 0.80
Plasma amino acid analysis by isotope ratio gas chromatography mass spectrometry computer techniques. Biomed Mass Spectrom (1975) 0.80
Continuous-flow isotope ratio mass spectrometry using the chemical reaction interface with either gas or liquid chromatographic introduction. Anal Chem (1996) 0.80
Distributions of charged hadrons associated with high transverse momentum particles in pp and Au+Au collisions at sqrt[sNN]=200 GeV. Phys Rev Lett (2005) 0.79
Calcitonin in tissues of thyroidectomized monkey. Experientia (1980) 0.79
Serum calcitonin may be a marker for inhalation injury in burns. J Burn Care Rehabil (1993) 0.79
Prenatal stress alters early neurobehavior, stress reactivity and learning in non-human primates: a brief review. Stress (2001) 0.79
Urine calcitonin as a test for medullary thyroid cancer: a new screening procedure. Ann Surg (1979) 0.79
Direct observation of dijets in central Au+Au collisions at sqrt[sNN]=200 GeV. Phys Rev Lett (2006) 0.79
Calcitonin as a marker for diethylnitrosamine-induced pulmonary endocrine cell hyperplasia in hamsters. Lab Invest (1984) 0.79
Size exclusion chromatography-chemical reaction interface mass spectrometry: "a perfect match". Anal Chem (1999) 0.78
Effects of cancer and its treatments on plasma concentration of alpha 1-acid glycoprotein and propranolol binding. Clin Pharmacol Ther (1982) 0.78
Open labeled, uncontrolled pharmacokinetic study of a single intramuscular hCG dose in healthy male volunteers. Int J Clin Pharmacol Ther (2009) 0.78
A moving belt device to couple high-performance liquid chromatography and chemical reaction interface mass spectrometry. Biol Mass Spectrom (1991) 0.78
Bioavailability, distribution and pharmacokinetics of diethystilbestrol produced from stilphostrol. J Urol (1982) 0.78
Urine calcitonin levels in patients with bronchogenic carcinoma. JAMA (1980) 0.78
Role of CT angiographic plaque morphologic characteristics in addition to stenosis in predicting the symptomatic side in carotid artery disease. AJNR Am J Neuroradiol (2010) 0.78
Modulation of pulmonary bombesin by nicotine and vagotomy. Life Sci (1990) 0.77
Why another examination? CMAJ (1992) 0.77
Subacute seizure incidence in thrombolysis-treated ischemic stroke patients. Neurocrit Care (2012) 0.77
Doubts, fears and misconceptions. What is the future of thrombolysis in acute stroke? Can J Neurol Sci (2000) 0.77
Hypercalcitonemia in inhalation burn injury: a response of the pulmonary neuroendocrine cell? Anat Rec (1993) 0.77